# Breast Cancer Staging TNM 8 — user reviews

> 7 indexed App Store user reviews of Breast Cancer Staging TNM 8 by Integrated Cancer Research Limited, rated 4.90/5 from 961 ratings.

- Source: https://appshunter.io/ios/app/breast-cancer-staging-tnm-8/id1218852568/reviews
- App overview in markdown: https://appshunter.io/ios/app/breast-cancer-staging-tnm-8/id1218852568.md
- Rating breakdown: 5★ 899 · 4★ 50 · 3★ 7 · 2★ 2 · 1★ 3

## Most critical reviews (7 lowest-rated)

### 5/5 — Invaluable

*2019-10-26*

Great app. Saves so much time sifting through the pages of tables in the manual. I don’t use the tables in the manual anymore.

### 5/5 — The Best Breast TNM App

*2018-06-17*

Very simple to use. 
The very first app of its kind. 
All others are copies. 
Congratulations!

### 5/5 — Simplifies the matrix

*2018-04-18*

This app takes the 21 page staging form into one easy screen! Excellent work wish I had it for desktop

### 5/5 — Useless don’t waste any money

*2018-04-03*

Sad app doesn’t do what it should for example if you clock HER+ it still asks for oncotype score even though an oncotype is never sent in HER+.

**Developer response:** Based on your feedback, if a patient presented with M1 involvement you would expect the app to remove all other staging fields (T, N, G...) as they have no impact on the staging?  You've left a negative review in attempts to prevent users from seeing OncotypeDx, not because the app doesn't work.

### 5/5 — Fantastic App!

*2017-11-14, version 6.41*

Extremely useful and easy to navigate your way around the app!

### 5/5 — Highly recommend

*2017-11-14, version 6.41*

Fantastic App.  It enables me to stage my patients accurately and effortlessly.  I highly recommend this App to anyone in the field of oncology.

### 5/5 — Amazing!

*2017-10-31*

Simple and easy to use. Not sure how I would have survived without it. Highly recommended.

---

*Data collected daily from the US App Store and indexed by [AppsHunter](https://appshunter.io/). User reviews are verbatim App Store reviews. Ratings, prices and chart positions refresh continuously; this snapshot is from 2026-06-10.*